Edition:
United Kingdom

BioScrip Inc (BIOS.OQ)

BIOS.OQ on NASDAQ Stock Exchange Global Select Market

3.02USD
23 Feb 2018
Change (% chg)

$0.03 (+1.00%)
Prev Close
$2.99
Open
$3.00
Day's High
$3.04
Day's Low
$2.98
Volume
72,485
Avg. Vol
227,261
52-wk High
$3.39
52-wk Low
$1.35

Chart for

About

BioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates... (more)

Overall

Beta: 0.27
Market Cap(Mil.): $369.68
Shares Outstanding(Mil.): 127.48
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.42 16.60
EPS (TTM): -- -- --
ROI: -- 6.44 10.66
ROE: -- 10.09 14.30

BRIEF-BioScrip Announces Additions To Senior Leadership Team

* BIOSCRIP - ‍ANNOUNCED APPOINTMENTS OF HARRIET BOOKER AS CHIEF OPERATING OFFICER, DANNY CLAYCOMB AS SENIOR VICE PRESIDENT, REVENUE CYCLE MANAGEMENT​ Source text for Eikon: Further company coverage:

28 Nov 2017

BRIEF-BioScrip can now dispense & administer radicava treatment option for amyotrophic lateral sclerosis

* BioScrip says can now dispense & administer Radicava (edaravone) treatment option for amyotrophic lateral sclerosis approved by U.S. FDA Source text for Eikon: Further company coverage:

05 Oct 2017

BRIEF-Coliseum Capital reports 14.6 pct stake in Bioscrip

* Coliseum Capital Management LLC reports 14.6 percent stake in Bioscrip Inc as of September 7, 2017 - SEC filing‍​

08 Sep 2017

Earnings vs. Estimates